Medline (MDLN) news

Biocon's Shaw: Biosimilars a very attractive segment

Biocon, India’s largest biopharmaceutical company, has positioned itself as a key player in the global biosimilars market, with its chairman and managing director, Kiran Mazumdar-Shaw, emphasizing the segment’s growing potential. The company recently received approval for its Glargine biosimilar in…

FDA: Medline reports no injuries or deaths as of July 31

As of July 31, 2026, the U.S. Food and Drug Administration (FDA) has been informed by Medline Industries, LP that no injuries or deaths have been reported in connection with the recent nationwide recall of certain Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits. The recall, initiated on…

FDA: Medline recalls Hudson RCI neonatal breathing circuits

On July 13, 2026, Medline Industries, LP announced a nationwide recall of certain Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits, following reports of sporadic failures in the electrical connectors of the devices. The affected circuits, used in conjunction with Neptune humidifiers, may…

Lone Pine boosts PFGC, Wulf, MDLN, USFD, CVNA in 2Q: 13F

Lone Pine Capital, a hedge fund managed by Steve Mandel, reported its second-quarter 13F filing on May 15, 2026, revealing several notable portfolio adjustments. The firm increased its positions in Performance Food Group (PFGC), Terawulf (WULF), Medline (MDLN), Us Foods (USFD), and Carvana (CVNA),…

Medline Inc.: TD Cowen cuts target price to $45 from $53